PHP
MTEM

Parkman Healthcare Partners’s Molecular Templates, Inc. MTEM Stock Holding History

Parkman Healthcare Partners’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,914
Closed -$358K – 91
2022
Q1 		$358K Sell
6,914
-2,935
-30% -$130K 0.1% 78
2021
Q4 		$579K Buy
9,849
+405
+4% +$30.3K 0.13% 82
2021
Q3 		$951K Hold
9,444
– – 0.24% 66
2021
Q2 		$1.11M Sell
9,444
-1,611
-15% -$211K 0.24% 70
2021
Q1 		$2.09M Buy
11,055
+381
+4% +$66.8K 0.49% 54
2020
Q4 		$1.5M Sell
10,674
-7,189
-40% -$1.06M 0.39% 66
2020
Q3 		$2.93M Sell
17,863
-4,995
-22% -$888K 0.77% 46
2020
Q2 		$4.73M Hold
22,858
– – 1.33% 32
2020
Q1 		$4.56M Buy
22,858
+78
+0.3% +$17.1K 2.11% 14
2019
Q4 		$4.78M Buy
+22,780
New +$3.27M 1.38% 27

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parkman Healthcare Partners's MTEM Position: Q2 2022 in Review

Parkman Healthcare Partners sold out of Molecular Templates, Inc. (MTEM) in Q2 2022, closing a stake of 6,914 shares — an estimated $358K sold.

Parkman Healthcare Partners first reported a position in MTEM in Q4 2019 and held it in 10 quarters. The position peaked at $4.78M in Q4 2019. 65 funds tracked by Wall St. Rank hold MTEM as of Q2 2022.

  • Parkman Healthcare Partners reported no remaining Molecular Templates, Inc. position as of Q2 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 6,914 Molecular Templates, Inc. shares in Q2 2022, an estimated $358K.
  • Parkman Healthcare Partners first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 10 quarters.
  • Parkman Healthcare Partners's Molecular Templates, Inc. position peaked at $4.78M in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q2 2022.

Based on Parkman Healthcare Partners's 13F filing for Q2 2022, filed 12 Aug 2022.